Is RSA Insurance Group plc A Contrarian Buy?

RSA Insurance Group plc (LON:RSA) is a falling knife this Fool might catch.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

We at the Fool have often said that the big insurers are a buy. We have already seen both Prudential and Aviva rocket outwards in value in recent months. Whilst Prudential was a successful play on emerging market growth, Aviva was a value play which is now paying dividends.

By comparison, RSA Insurance Group plc (LSE: RSA) (NASDAQOTH: RSANY.US) has been a bit of a laggard. Since the Credit Crunch it has been pretty much range bound. Recently the share price has been recovering steadily.

The share price has taken a tumble

But storms and adverse weather in the UK and in Canada have affected the company’s profits this year. And then there was the news about accounting irregularities in Ireland. Not surprisingly, RSA’s share price has taken a tumble.

After its share price fall, is RSA now a contrarian buy? When a share price falls like this, the first thing I check are the fundamentals — from this I work out whether the share price will fall and fall, or whether it will bounce and then recover. So, let’s analyse the numbers.

The forward P/E ratio is now 16. By this measure, the company is no longer cheap. But dig a little deeper, and we find that profits are expected to return to normal levels the following year, and the P/E ratio is likely to fall below 10.

Yet the fundamentals are good

It is also worth noting that the company is selling at close to book value. And there is a dividend yield of 6%. All these indicators suggest that the company is cheap.

What’s more, this is a strong, stable company with significant scale and which has a range of profitable, growing businesses around the world. This is no fly-by-night outfit. The controversy in Ireland is worrying, but I wouldn’t overplay its impact.

My view is that RSA’s share price fall is a reaction to the storm losses and accounting irregularities rather than a symptom of long-term troubles. Premiums have actually increased substantially, with emerging markets rocketing outwards.

So this is a share which I think contrarians should be thinking seriously of buying into. It is certainly on my watch list, and I am waiting patiently for this falling knife to hit the floor before buying in. Once the share price bottoms, RSA is a definite contrarian buy.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

> Prabhat doesn't own shares in any of the companies mentioned in this article.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »